BioCryst Pharmaceuticals ... (BCRX)
NASDAQ: BCRX
· Real-Time Price · USD
8.37
-0.08 (-0.95%)
At close: Aug 15, 2025, 3:59 PM
8.39
0.30%
After-hours: Aug 15, 2025, 06:15 PM EDT
BioCryst Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 163.35M | 145.53M | 131.53M | 117.08M | 109.33M | 92.76M | 93.4M | 86.74M | 82.49M | 68.78M | 79.55M | 75.83M | 65.53M | 49.92M | 47.16M | 40.99M | 49.96M | 19.06M |
Cost of Revenue | 2.8M | 4.57M | 6.13M | 3.23M | 2.05M | 1.26M | 2.06M | 1.14M | 950K | 938K | 2.5M | 3.61M | 247K | 238K | 419K | 615K | 343K | 5.92M |
Gross Profit | 160.56M | 140.97M | 125.4M | 113.86M | 107.6M | 91.5M | 91.34M | 85.19M | 81.13M | 67.84M | 77.05M | 72.21M | 65.28M | 49.69M | 46.74M | 40.38M | 49.62M | 13.14M |
Operating Income | 29.79M | 21.23M | -4.51M | 7.69M | 8.76M | -14.49M | -42.67M | -11.92M | -20.7M | -28.41M | -46.31M | -17.45M | -34.72M | -49.96M | -52.18M | -44.58M | -29.58M | -51.38M |
Interest Income | 2.52M | 3.02M | 3.57M | 3.59M | 3.55M | 4.03M | 4.46M | 4.18M | 3.75M | 3.38M | 2.7M | 1.76M | 609K | 54K | 14K | 9K | 13K | 26K |
Pretax Income | 6.49M | 758K | -25.99M | -13.45M | -12.5M | -35.01M | -63.16M | -35.82M | -74.59M | -52.66M | -71.47M | -41M | -58M | -73.92M | -15.53M | -58.8M | -43.2M | -64.28M |
Net Income | 5.08M | 32K | -26.8M | -14.03M | -12.67M | -35.38M | -61.73M | -36.15M | -75.33M | -53.33M | -71.54M | -42.52M | -58.86M | -74.2M | -17.78M | -58.8M | -43.2M | -64.28M |
Selling & General & Admin | 87.38M | 82.47M | 80.47M | 65.08M | 61.21M | 59.36M | 64.38M | 50.65M | 51M | 47.87M | 50.15M | 36.92M | 38.02M | 34.28M | 35.39M | 34.99M | 26.32M | 22.11M |
Research & Development | 43.39M | 37.27M | 49.44M | 41.08M | 37.62M | 46.49M | 70.05M | 46.88M | 51.25M | 48.39M | 73.21M | 52.74M | 61.99M | 65.36M | 63.53M | 49.97M | 52.87M | 42.44M |
Other Expenses | n/a | n/a | n/a | n/a | 35K | 127K | n/a | n/a | n/a | 7K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -36K |
Operating Expenses | 130.77M | 119.74M | 129.91M | 106.17M | 98.52M | 105.86M | 134.01M | 97.53M | 102.24M | 96.25M | 123.36M | 89.66M | 100.01M | 99.64M | 98.92M | 84.96M | 79.2M | 64.51M |
Interest Expense | -68.57M | 23.49M | 24.45M | 24.83M | 24.73M | 24.51M | 24.58M | 27.34M | 28.91M | 27.4M | 26.46M | 24.77M | 24.02M | 23.84M | 18.78M | 14.12M | 13.49M | 12.9M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 14.4M | n/a | 3.29M | 4.05M | 3.34M | n/a | 4.09M | 3.98M | 1.01M | 1.49M | 1.8M | 1.4M |
Cost & Expenses | 133.57M | 124.31M | 136.04M | 109.39M | 100.57M | 107.25M | 136.07M | 98.66M | 103.19M | 97.19M | 125.86M | 93.27M | 100.25M | 99.88M | 99.33M | 85.58M | 79.54M | 70.44M |
Income Tax Expense | 1.4M | 726K | 804K | 586K | 172K | 365K | -1.43M | 330K | 740K | 671K | 76K | 1.52M | 856K | 279K | 2.25M | n/a | n/a | n/a |
Shares Outstanding (Basic) | 209.2M | 208.88M | 207.38M | 206.91M | 206.43M | 206.06M | 201.41M | 189.64M | 189.12M | 188.51M | 186.92M | 186.18M | 183.93M | 184.9M | 181.84M | 179.11M | 178.13M | 177.34M |
Shares Outstanding (Diluted) | 219.89M | 215.26M | 207.38M | 206.91M | 206.43M | 206.06M | 201.41M | 189.64M | 189.12M | 188.51M | 186.92M | 186.18M | 185.6M | 184.9M | 181.84M | 179.11M | 178.13M | 177.34M |
EPS (Basic) | 0.02 | 0.00 | -0.13 | -0.07 | -0.06 | -0.17 | -0.31 | -0.19 | -0.4 | -0.28 | -0.38 | -0.23 | -0.32 | -0.4 | -0.1 | -0.33 | -0.24 | -0.36 |
EPS (Diluted) | 0.02 | 0.00 | -0.13 | -0.07 | -0.06 | -0.17 | -0.31 | -0.19 | -0.4 | -0.28 | -0.38 | -0.23 | -0.32 | -0.4 | -0.1 | -0.33 | -0.24 | -0.36 |
EBITDA | -62.41M | 24.58M | -1.23M | 11.69M | 8.76M | -10.2M | -38.16M | -8.05M | -45.26M | -24.86M | -44.61M | -15.83M | -33.65M | -49.76M | -59.01M | -44.46M | -29.5M | -51.2M |
EBIT | 28.07M | 24.25M | -1.54M | 11.38M | 12.23M | -10.51M | -38.58M | -8.47M | -45.67M | -25.27M | -45.01M | -16.22M | -33.98M | -50.08M | 3.25M | -44.69M | -29.7M | -51.38M |
Depreciation & Amortization | -331K | 331K | 309K | 311K | 320K | 306K | 423K | 420K | 407K | 405K | 396K | 389K | 335K | 317K | 171K | 229K | 199K | 178K |